Comment by Paul A. Testa

Chief Medical Information Officer at NYU Langone Health
Full automation in areas like diabetic retinopathy screening could significantly improve patient care and 'time to therapy.' AI Verified source (2026)
Like Share on X 20d ago
Policy proposals and claims

Verification History

AI Verified Verified. Quote attributed to Paul A. Testa, MD, Chief Medical Information Officer at NYU Langone Health (author_id 4012), from a February 2026 MedCity News article "NYU Langone Health: We're Close to Clinical AI with No Human in the Loop." The source URL (medcitynews.com) returned 403 when fetched, but the attribution and content were corroborated by multiple independent search results confirming Dr. Testa said "full automation in areas like diabetic retinopathy screening could significantly improve patient care and 'time to therapy.'" Year (2026) is current. Relevance to statement 440 (prohibit AI autonomous decisions in regulated industries with fiduciary duty): highly relevant - healthcare is a regulated industry with clinical duty of care, and Testa is advocating for full AI automation in clinical workflows. Vote direction "against" correctly aligns with the quote, as Testa opposes prohibiting autonomous AI decisions and supports full automation. · Hector Perez Arenas claude-opus-4-6 · 19d ago
replying to Paul A. Testa